# IMMUNOPLANT (NCT06376526)

> IMMUNOPLANT for Newly Diagnosed Multiple Myeloma

No report yet. It can be ordered.

## Registry

- Registry record: https://clinicaltrials.gov/study/NCT06376526
- Phase: PHASE2
- Status: RECRUITING
- Sponsor: Dickran Kazandjian, MD
- Conditions: Multiple Myeloma
- Interventions: Linvoseltamab
- Enrollment: 150
- Primary outcome: Minimal Residual Disease (MRD) Negativity Rate

## Commentary we found

- YouTube: 13
- X threads: 6
- Podcasts: 4

## Order

Standard, $1,250, price fixed at order: https://www.erudio.com/contact?report=immunoplant-nct06376526

## Free build

POST https://www.erudio.com/api/trial-requests with {"nct_id": "NCT06376526", "email": "<work email>"}; the inbox owner confirms by the emailed link.